Literature DB >> 12801610

Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARgamma, but not cytokine production, by human monocyte-macrophages.

Ian C Kavanagh1, Carole E Symes, Pauline Renaudin, Esther Nova, Maria Dolores Mesa, George Boukouvalas, David S Leake, Parveen Yaqoob.   

Abstract

Oxidized low-density lipoprotein (oxLDL) exhibits many atherogenic effects, including the promotion of monocyte recruitment to the arterial endothelium and the induction of scavenger receptor expression. However, while atherosclerosis involves chronic inflammation within the arterial intima, it is unclear whether oxLDL alone provides a direct inflammatory stimulus for monocyte-macrophages. Furthermore, oxLDL is not a single, well-defined entity, but has structural and physical properties which vary according to the degree of oxidation. We tested the hypothesis that the biological effects of oxLDL will vary according to its degree of oxidation and that some species of oxLDL will have atherogenic properties, while other species may be responsible for its inflammatory activity. The atherogenic and inflammatory properties of LDL oxidized to predetermined degrees (mild, moderate and extensive oxidation) were investigated in a single system using human monocyte-derived macrophages. Expression of CD36 mRNA was up-regulated by mildly- and moderately-oxLDL, but not highly-oxLDL. The expression of the transcription factor, proliferator-activated receptor-gamma (PPARgamma), which has been proposed to positively regulate the expression of CD36, was increased to the greatest degree by highly-oxLDL. However, the DNA binding activity of PPARgamma was increased only by mildly- and moderately-oxLDL. None of the oxLDL species appeared to be pro-inflammatory towards monocytes, either directly or indirectly through mediators derived from lymphocytes, regardless of the degree of oxidation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801610     DOI: 10.1016/s0021-9150(03)00148-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARgamma mRNA expression and modulates SR-BI gene expression in murine macrophages.

Authors:  Thomas Westendorf; Juergen Graessler; Steffi Kopprasch
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

2.  Hidden disease susceptibility and sexual dimorphism in the heterozygous knockout of Cyp51 from cholesterol synthesis.

Authors:  Monika Lewinska; Peter Juvan; Martina Perse; Jera Jeruc; Spela Kos; Gregor Lorbek; Ziga Urlep; Rok Keber; Simon Horvat; Damjana Rozman
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

3.  Macrophage uptake of oxidized and acetylated low-density lipoproteins and generation of reactive oxygen species are regulated by linear stiffness of the growth surface.

Authors:  Erika J Gruber; Ali Y Aygun; Cynthia A Leifer
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

4.  Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation.

Authors:  Kousei Ohshima; Masaki Mogi; Masatsugu Horiuchi
Journal:  Int J Vasc Med       Date:  2012-07-24

5.  Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model.

Authors:  Y Hernandez-Trujillo; F Rodriguez-Esparragon; A Macias-Reyes; A Caballero-Hidalgo; Jose C Rodriguez-Perez
Journal:  Cardiovasc Diabetol       Date:  2008-02-26       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.